Log In
Print
BCIQ
Print
Print this Print this
 

LL-37

  Manage Alerts
Collapse Summary General Information
Company Pergamum AB
DescriptionTopical gel formulation of cathelicidin antimicrobial peptide (CAMP; LL37)
Molecular Target Cathelicidin antimicrobial peptide (CAMP) (LL37)
Mechanism of Action 
Therapeutic ModalityPeptide
Latest Stage of DevelopmentPhase I/II
Standard IndicationDermal ulcers
Indication DetailsTreat chronic venous leg ulcers
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today